Clinical Trials
3 trialsNCT03921515 2024-12-13
Skin Immunity Sample Collection Involving Blisters and Biopsies
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Withdrawn
NCT01321879 2019-12-27
Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02502474 2018-09-28
ColoStaph
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Completed